Zhou Yan-Yuan, Wang Shao-Chung, Seak Chen-June, Huang Shu-Wei, Cheng Hao-Tsai
School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Department of Medical Imaging and Intervention, New Taipei Municipal Tucheng Hospital, Chang Gung Medical foundation, New Taipei City, Taiwan.
Front Med (Lausanne). 2023 Jun 22;10:1198378. doi: 10.3389/fmed.2023.1198378. eCollection 2023.
Visceral artery pseudoaneurysm is a rare disease that most commonly occurs in male patients in their 50s, with gastroduodenal artery (GDA) pseudoaneurysm accounting for only 1.5% of these. The treatment options generally include open surgery and endovascular treatment. In 40 cases of GDA pseudoaneurysm from 2001 to 2022, endovascular therapy was the mainstay of treatment in 30 cases, and most of them (77%) were treated by coil embolization. Our case report describes a 76-year-old female patient with a GDA pseudoaneurysm, which was treated by endovascular embolization using liquid embolic agent N-butyl-2-cyanoacrylate (NBCA) alone. This is the first time this treatment strategy has been used for GDA pseudoaneurysm. We demonstrate a successful outcome with this unique treatment. The successful experience of our case may provide a new treatment strategy for this rare disease.
内脏动脉假性动脉瘤是一种罕见疾病,最常见于50多岁的男性患者,其中胃十二指肠动脉(GDA)假性动脉瘤仅占1.5%。治疗选择通常包括开放手术和血管内治疗。在2001年至2022年的40例GDA假性动脉瘤病例中,30例以血管内治疗为主,其中大多数(77%)采用弹簧圈栓塞治疗。我们的病例报告描述了一名76岁的女性GDA假性动脉瘤患者,仅使用液体栓塞剂N-丁基-2-氰基丙烯酸酯(NBCA)进行血管内栓塞治疗。这是首次将这种治疗策略用于GDA假性动脉瘤。我们展示了这种独特治疗的成功结果。我们病例的成功经验可能为这种罕见疾病提供一种新的治疗策略。